Stay up to date with respiratory news & updates by subscribing to receive the free RPM print publications or e‑Newsletters.
Respiratory practices have faced unique challenges as a result of the COVID-19 pandemic. Respiratory Practice Management recently interviewed Elizabeth Johnson, LPN, CPC, PACS, Lead Biologics Coordinator, Allergy Partners, Asheville, NC, to discuss these challenges and how practices can respond accordingly to maintain financial stability amid these uncertain times.
At the beginning of the pandemic, practices witnessed substantial decreases in patient volume. “Patients panicked. We had to figure out how to make them feel comfortable and feel safe to come back,” noted Ms Johnson. As a result, practices instituted numerous safety measures to protect their patients, clinicians, and office staff.
During this time, the use of telemedicine expanded dramatically. For routine visits and follow-up appointments, telemedicine is a great option, according to Ms Johnson. Routine prescription refills of epinephrine autoinjectors and yearly medication refills can be accomplished via telemedicine appointments. The use of telemedicine, however, cannot replace all in-person visits. For example, patients must still come into the office for such procedures as allergy shots, skin testing, and food allergy assessments.
The COVID-19 pandemic has also disrupted the revenue cycle for practices. Initially, reduced patient volume was the primary cause, although external factors contributed to this issue as well. Employees of payer organizations transitioned to working from home and manpower and communication shifted. Some claims departments are still experiencing slower processing times due, in large part, to the increased volume of telemedicine. Prior authorizations have also been a challenge, particularly in the biologics space. Ms Johnson said that a lack of communication within some payer systems led to initial denials of claims despite automatic authorization extensions already being in place because of the pandemic.
Despite these challenges, practices can remain financially solvent and even thrive. The Coronavirus Aid, Relief, and Economic Security Act has provided assistance to small businesses, including medical practices.1 The Paycheck Protection Program, administered through the Small Business Administration, has also been helpful—particularly for smaller practices. In many cases, the Paycheck Protection Program has allowed practices to keep their doors open during these challenging times.
Ms Johnson identified 3 key strategies that practices should adopt:
Similarly, patients’ families will be affected by changes in school schedules and the workforce. Practices should evaluate patient demographics to consider the adjustment of scheduling needs and to determine whether extended office hours might be beneficial. Changes made with respect to extending office hours or adding weekend availability should be advertised widely, to ensure that patients are aware of these new resources. Practices should make use of websites, newsletters, e-mails, and social media to get the word out.
The COVID-19 pandemic has presented practices with many new challenges that will continue into the foreseeable future. Responding to these hurdles requires planning and flexibility, but respiratory practices can survive and even thrive during these uncertain times.
Read Now